Alcon AG | ALC - Nettoeinkommen

Aktienkurs
59.20
Täglich Wechseln
-0.20 -0.34%
Monatlich
-9.40%
Jährlich
-28.09%
Q1 Prognose
57.57




Nettoeinkommen Veränderung Datum
AstraZeneca USD 2.33B 207M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Essilor EUR 928M 459M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
GRIFOLS EUR 98.25M 28.72M 2025-12
Lonza CHF 426M 119M 2025-06
Merck EUR 319M 583M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Philips EUR 395M 211M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Smith & Nephew USD 293M 79M 2025-12
Sonova Holding CHF 188.5M 143.4M 2025-12
UCB EUR 1.08B 608M 2025-12